Online ads

As pharma dives deeper into digital, ad fraud is getting worse

Short on Time?

  • Adalytics reported that for nine months, billions of ad auctions for space on Gannett’s USA Today website resulted in brands unknowingly getting stuck with their ads running on other Gannett sites — often remote community sites.
  • Ads from who-knows-how-many companies ran in the wrong places for nine months.
  • Not a single brand noticed this, and not a single media buyer noticed the fraud.
  • Online ad fraud is costing pharma millions
Continue reading →

If your agency is recommending programmatic ad buying, change agencies

  • According to research conducted by a professor at MIT programmatic ad buys may not just be unproductive, it may be counterproductive.
  • 3rd party data may be useless at the most elementary of targeting tasks.
  • Using data acquired from 3rd party brokers improved targeting performance by 184%,but creates extra costs of about 238% on average in comparison to random placements.
  • Adobe inspected traffic across thousands of its client sites and found that 28% of the traffic showed “non-human signals” indicating that it was fraudulent.
Continue reading →

Should pharma abandon online ads?

KEY TAKEAWAY: The online ad industry is in deep trouble.  Marketers are questioning online ad effectiveness and consumers are sick and tired of viewing irrelevant ads when they are paying through the nose for broadband access.  Pharma should not abandon online ads, but rather invest more time and effort to ensure they provide an adequate ROI.

Continue reading →